Global Medical Imaging Reagents Market Segments 2024, Forecast To 2033
5 Mar, 2024
The medical imaging reagents market has demonstrated robust growth, rising from $14.06 billion in 2023 to $15.13 billion in 2024, with a 7.6% CAGR. Increased disease prevalence and strategic collaborations contributed to historic growth. The market is projected to reach $19.52 billion in 2028, reflecting a 6.6% CAGR. Anticipated trends involve technological advancements, focus on early disease detection, and expanding point-of-care imaging, aligning with the industry's emphasis on innovation and personalized medicine.
Global Medical Imaging Reagents Market Key Driver
The medical imaging reagents market is growing with the increase in the prevalence of chronic diseases. In 2021, an estimated 1.9 million new cancer cases and 609,360 cancer deaths were reported in the United States, emphasizing the need for diagnostic solutions.
Get A Free Sample Of The Global Medical Imaging Reagents Market ReportGlobal Medical Imaging Reagents Market Segments
The medical imaging reagents market covered in this report is segmented –
1) By Class: Contrast Reagents, Optical Reagents, Nuclear Reagents
2) By Technology: Nanoparticles, Fluorescent Dyes, Probes Radiopharmaceuticals, Fluorescent Proteins, Quantum Dots
3) By Modality: X-ray, CT Scan, Ultrasound, MRI Scan
4) By Application: Neurological Disorder, Cardiovascular Disorder, Cancer, Gastrointestinal Disorder, Musculoskeletal Disorder, Nephrological Disorder, Other Applications
5) By End User: Biotechnology Companies, Pharmaceutical Companies, Diagnostic Labs
By Geography: The regions covered in the anti inflammatory therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa. Among these regions.
North America was the largest region in the medical imaging reagents market in 2023. The regions covered in the medical imaging reagents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major Medical Imaging Reagents Industry Players
General Electric Company; Lantheus Holdings Inc.; Thermo Fisher Scientific Inc.; Bayer AG; Bracco SpA; Siemens AG; PerkinElmer Inc.; Cardinal Health Inc.; Shimadzu Corporation; Philips Healthcare; SA Laboratoires André Guerbet; Li-cor Biosciences Inc.; Canon Medical Systems Corporation; Fujifilm Healthcare; Aidoc Medical; Guerbet Group; Lantheus Medical Imaging Inc.; Merck KGaA; Beckman Coulter Inc.; Agilent Technologies Inc.; Bio-Rad Laboratories Inc.; Bio-Techne Corporation; Esaote SpA; Hitachi Ltd.; Koninklijke Philips N.V.; Toshiba Corporation; Hologic Inc.; Carestream Health Inc.; Curium Pharma; Nordion Inc.; IBA Molecular; Eckert & Ziegler Radiopharma GmbH; Advanced Accelerator Applications; Jubilant Life Sciences Limited; Mallinckrodt Pharmaceuticals; Rotem Industries Ltd.; JFE Engineering Corporation; Nihon Kohden Corporation; Mindray Medical International Limited; Samsung Medison Co. Ltd.; Analogic Corporation
Get The Full Global Medical Imaging Reagents Market Report
AIOps Medical Imaging Reagents Market Overview
Medical imaging reagents refer to the substances that are used by medical practitioners and researchers to enhance the visibility of the structures and organs to identify new development and diagnose or treat diseases. It is used to visualize structures or organs, allowing clinicians to better diagnose and identify diseases.
Medical Imaging Reagents Global Market Report 2023 provides data on the global medical imaging reagents market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The medical imaging reagents market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.